Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Joyn
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Joint venture between Bayer and Ginkgo Bioworks to manufacture microbial products using synthetic biology for more efficient and sustainable crop fertilizers

Founded in 2017
Founded in

Company type Private Public ()
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 4-6
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Boston, MA Boston, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by at on 01/24/2025

Edited by Cleantech Group on 01/24/2025

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
07/22/2019
NewLeaf Symbiotics NewLeaf Symbiotics
NewLeaf Symbiotics and Joyn Bio have announced a long-term partnership valued at up to $75 million to bring a new microbe class that the firms say will benefit crop health and protection. Through this deal, Joyn Bio will gain access to NewLeaf’s library of proprietary, highly characterized strains of plant colonizing microbes.
View source    
Confirmed by NewLeaf Symbiotics
Development Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Cancel Save
Add Investment
Date Investors Type Amount
09/14/2017 Bayer Bayer , Ginkgo Bioworks Ginkgo Bioworks , Viking Global Viking Global (3)
Post-money valuation of
The startup plans to hire 50 people and have offices at Ginkgo's Boston facilities and in Sacramento, California, home to Bayer's plant biologics test facilities.
 Series A $100,000,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font